Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 2/20 | 0.68 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.68 |
| ▸ | CYP11B2 | P19099 | 4/20 | 0.59 |
| ▸ | CYP11B1 | P15538 | 3/20 | 0.59 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.59 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.59 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.57 |
| ▸ | ESR1 | P03372 | 1/20 | 0.57 |
| ▸ | ABL1 | P00519 | 2/20 | 0.57 |
| ▸ | ABCB1 | P08183 | 2/20 | 0.57 |
| ▸ | BCR | P11274 | 2/20 | 0.57 |
| ▸ | NPC1 | O15118 | 3/20 | 0.55 |
| ▸ | RAB9A | P51151 | 3/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.55 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.55 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.55 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.55 |
| ▸ | RELA | Q04206 | 1/20 | 0.55 |
| ▸ | MAPT | P10636 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4017171 | 0.94 | CYP1A2 (0.59) | CYP1A2CYP2A6CYP11B2CYP11B1HSD17B1 | |
| SCHEMBL29847312 | 0.94 | CYP1A2 (0.59) | CYP1A2CYP2A6CYP11B2CYP11B1HSD17B1 | |
| SCHEMBL29847374 | 0.94 | CYP1A2 (0.59) | CYP1A2CYP2A6CYP11B2CYP11B1HSD17B1 | |
| SCHEMBL25041887 | 0.91 | CYP1A2 (0.83) | CYP1A2CYP2A6CYP11B2CYP11B1HSD17B1 | |
| SCHEMBL28147639 | 0.91 | HSD17B1 (0.68) | CYP1A2CYP2A6CYP11B2CYP11B1HSD17B1 | |
| SCHEMBL29588373 | 0.89 | CYP1A2 (0.79) | CYP1A2CYP2A6CYP11B2CYP11B1HSD17B1 | |
| SCHEMBL11978648 | 0.89 | CYP1A2 (0.79) | CYP1A2CYP2A6CYP11B2CYP11B1HSD17B1 | |
| SCHEMBL13367666 | 0.88 | CYP1A2 (0.53) | CYP1A2CYP2A6CYP11B2CYP11B1HSD17B1 | |
| SCHEMBL5981250 | 0.87 | HSD17B1 (0.70) | CYP1A2CYP2A6CYP11B2CYP11B1HSD17B1 | |
| SCHEMBL28104773 | 0.86 | HSD17B1 (0.63) | CYP1A2CYP2A6CYP11B2CYP11B1HSD17B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116041153-B | Direct cross coupling method of aryl thioether and aryl bromine | 南京工业大学 | 2024-05-24 | — | — | CN | disclosed |
| CN-116041153-A | Direct cross coupling method of aryl thioether and aryl bromine | 南京工业大学 | 2023-05-02 | — | — | CN | disclosed |
| US-20210384430-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC APPARATUS PROVIDED WITH THE SAME | IDEMITSU KOSAN CO.,LTD. (JP) | 2021-12-09 | — | — | US | disclosed |
| US-10811612-B2 | Organic electroluminescence device and electronic apparatus provided with the same | IDEMITSU KOSAN CO., LTD. (JP) | 2020-10-20 | — | — | US | disclosed |
| US-20200111965-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC APPARATUS PROVIDED WITH THE SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2020-04-09 | — | — | US | disclosed |
| US-20200111962-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC APPARATUS PROVIDED WITH THE SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2020-04-09 | — | — | US | disclosed |
| US-9708351-B2 | Alkenes as alkyne equivalents in radical cascades terminated by fragmentations | The Florida State University Research Foundation, Inc. (US) | 2017-07-18 | — | — | US | disclosed |
| US-9708351-B2 | Alkenes as alkyne equivalents in radical cascades terminated by fragmentations | The Florida State University Research Foundation, Inc. (US) | 2017-07-18 | — | — | US | disclosed |
| US-9708351-B2 | Alkenes as alkyne equivalents in radical cascades terminated by fragmentations | The Florida State University Research Foundation, Inc. (US) | 2017-07-18 | — | — | US | disclosed |
| US-20160347778-A1 | ALKENES AS ALKYNE EQUIVALENTS IN RADICAL CASCADES TERMINATED BY FRAGMENTATIONS | The Florida State University Research Foundation, Inc. | 2016-12-01 | — | — | US | disclosed |
| US-20090145483-A1 | Novel electroluminescent compounds and organic electroluminescent device suing the same | GRACEL DISPLAY INC. (KR) | 2009-06-11 | — | — | US | disclosed |
| US-20090078317-A1 | Organometalic compounds for electroluminescence and organic electroluminescent device using the same | GRACEL DISPLAY INC. (KR) | 2009-03-26 | — | — | US | disclosed |
| WO-2009021750-A2 | TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY | SUMMIT CORPORATION PLC (GB) | 2009-02-19 | — | — | WO | disclosed |
| US-7067524-B2 | Substituted phenyl naphthalenes as estrogenic agents | WYETH (US) | 2006-06-27 | — | — | US | disclosed |
| CN-1738788-A | Substituted phenylnaphthalenes as estrogenic agents | WYETH CORP (US) | 2006-02-22 | — | — | CN | disclosed |
| US-6914074-B2 | Substituted phenyl naphthalenes as estrogenic agents | WYETH (US) | 2005-07-05 | — | — | US | disclosed |
| US-20040225123-A1 | Substituted phenyl naphthalenes as estrogenic agents | MEWSHAW RICHARD E (US) | 2004-11-11 | — | — | US | disclosed |
| EP-1453782-A2 | SUBSTITUTED PHENYL NAPHTHALENES AS ESTROGENIC AGENTS | Wyeth (US) | 2004-09-08 | — | — | EP | disclosed |
| US-20030181519-A1 | Substituted phenyl naphthalenes as estrogenic agents | WYETH | 2003-09-25 | — | — | US | disclosed |
| WO-2003051805-A2 | SUBSTITUTED PHENYL NAPHTHALENES AS ESTROGENIC AGENTS | WYETH (US) | 2003-06-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200111965-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC APPARATUS PROVIDED WITH THE SAME | RER1, RPS19, ESR1 | CYP1A2 1809/4885CYP2A6 2859/4885CYP11B2 1428/4885 |
| US-20030181519-A1 | Substituted phenyl naphthalenes as estrogenic agents | ESR2, ESR1, ESRRA | CYP1A2 342/4885CYP2A6 139/4885CYP11B2 257/4885 |
| US-20090145483-A1 | Novel electroluminescent compounds and organic electroluminescent device suing the same | LEF1, ODC1, AOC2 | CYP1A2 1920/4885CYP2A6 4133/4885CYP11B2 2615/4885 |
| US-20090078317-A1 | Organometalic compounds for electroluminescence and organic electroluminescent device using the same | OCIAD1, L1CAM, OCIAD2 | CYP1A2 1002/4885CYP2A6 2139/4885CYP11B2 1643/4885 |
| US-10811612-B2 | Organic electroluminescence device and electronic apparatus provided with the same | RER1, RPS19, ESR1 | CYP1A2 1809/4885CYP2A6 2859/4885CYP11B2 1428/4885 |
| US-20040225123-A1 | Substituted phenyl naphthalenes as estrogenic agents | ESR2, ESR1, ESRRA | CYP1A2 342/4885CYP2A6 139/4885CYP11B2 257/4885 |
| US-20160347778-A1 | ALKENES AS ALKYNE EQUIVALENTS IN RADICAL CASCADES TERMINATED BY FRAGMENTATIONS | AOC3, OR51E2, AOC2 | CYP1A2 444/4885CYP2A6 666/4885CYP11B2 77/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.